Our data reveals that IL-1β level was significantly increase in the COVID-19 positive patients, and this level significantly increases in ICU admitted patients; this makes IL-1β a good predictor of the disease severity and patient’s outcome. This evidence concerns the gene IL1B and COVID-19.